Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Peptic Ulcers

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    13 result(s) found for: Peptic Ulcers. Displaying page 1 of 1.
    EudraCT Number: 2006-005454-76 Sponsor Protocol Number: GAS-04-04 Start Date*: 2004-10-01
    Sponsor Name:IRCCS CASA SOLLIEVO DELLA SOFFERENZA
    Full Title: PPI as an adjunct to endoscopic hemostasis for bleeding peptic ulcer a randomized clinical trial of a high vs a standard regimen for the i.v. drug infusion
    Medical condition: Patients with peptic ulcer bleeding
    Disease: Version SOC Term Classification Code Term Level
    8.1 10034344 Peptic ulcer haemorrhage LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-005073-22 Sponsor Protocol Number: D961FC00003 Start Date*: 2007-01-23
    Sponsor Name:AstraZeneca AB
    Full Title: A randomized, double-blind, parallel-group study to assess the effect of esomeprazole 20 and 40 mg od versus placebo on the occurrence of peptic ulcers during 26 weeks in patients on continous low-...
    Medical condition: Target subject population are male and female subjects requiring low-dose acetylsalicylic acid (75-325 mg daily) who are Helicobacter pylori negative and who are at increased risk of developing ga...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10017886 Gastroduodenal ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed) PT (Completed) CZ (Completed) DE (Completed) SK (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2005-004849-33 Sponsor Protocol Number: Asp-Fam-01 Start Date*: 2005-12-21
    Sponsor Name:NHS Greater Glasgow
    Full Title: Prevention of oesophagitis, gastric and duodenal lesions in patients taking antithrombotic low-dose aspirin with famotidine
    Medical condition: Peptic ulceration induced by low-dose aspirin
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-003425-96 Sponsor Protocol Number: 11091 Start Date*: 2011-12-15
    Sponsor Name:University of Nottingham
    Full Title: Helicobacter eradication to prevent ulcer bleeding in aspirin users: a large simple randomised controlled trial
    Medical condition: Helicobacter eradication to prevent ulcer bleeding in aspirin users
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2019-002668-28 Sponsor Protocol Number: HP-301 Start Date*: 2020-04-21
    Sponsor Name:Phathom Pharmaceuticals, Inc.
    Full Title: A Phase 3 Randomized Multicenter Study to Evaluate the Efficacy and Safety of Open-Label Dual Therapy with Oral Vonoprazan 20 mg or Double-Blind Triple Therapy with Oral Vonoprazan 20 mg Compared t...
    Medical condition: Helicobacter pylori infection
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004862 10019377 Helicobacter pylori infection LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: HU (Completed) GB (GB - no longer in EU/EEA) CZ (Completed) PL (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2010-019064-36 Sponsor Protocol Number: MA-PY-Hp09-01 Start Date*: 2011-07-17
    Sponsor Name:Axcan Pharma INC
    Full Title: Eficacia y seguridad de PYLERA (subcitrato potásico de bismuto, metronidazol y clorhidrato de tetraciclina) con omeprazol, administrados 10 días en sujetos con fracaso del tratamiento de erradicaci...
    Medical condition: erradicación de Helicobacter pylori
    Disease: Version SOC Term Classification Code Term Level
    14.0 10021881 - Infections and infestations 10019377 Helicobacter pylori infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) DE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-006280-78 Sponsor Protocol Number: PYLHp07-01 Start Date*: 2008-03-28
    Sponsor Name:Axcan Pharma Inc.
    Full Title: Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omep...
    Medical condition: Helicobacter pylori infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019377 Helicobacter pylori infection LLT
    9.1 10021881 Infections and infestations SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) GB (Completed) IE (Completed) DE (Completed) NL (Completed) PL (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-001877-13 Sponsor Protocol Number: TMT107235 Start Date*: 2006-08-24
    Sponsor Name:GlaxoSmithKline Research & Development Ltd
    Full Title: A randomised, double-blind, double-dummy, parallel-group, placebo-controlled study comparing correlates of brain functional activation before and after treatment with placebo, active comparator par...
    Medical condition: Major Depressive Disorder
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-004889-17 Sponsor Protocol Number: MAD 105516 Start Date*: 2006-05-23
    Sponsor Name:GlaxoSmithKline Research and Development Limited
    Full Title: A randomized, double-blind, placebo-controlled, crossover study to evaluate the effects of morning administration of GW679769 (10mg and 30 mg) on polysomnograph sleep recordings, subjective sleep a...
    Medical condition: Primary insomnia
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-004984-32 Sponsor Protocol Number: NKF100096 Start Date*: 2005-06-10
    Sponsor Name:GlaxoSmithKline Research and Development Limited
    Full Title: A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects with Major Depres...
    Medical condition: Major Depressive Disorder (MDD)
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SK (Completed) SE (Completed) DE (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-000236-16 Sponsor Protocol Number: IPX056-B06-03 Start Date*: 2007-05-28
    Sponsor Name:IMPAX Laboratories, Inc.
    Full Title: A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects with Establis...
    Medical condition: Established Spasticity Resulting from Multiple Sclerosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10041416 Spasticity LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: EE (Completed) LV (Completed)
    Trial results: View results
    EudraCT Number: 2008-001892-31 Sponsor Protocol Number: HPL08001HCLAD Start Date*: 2008-09-29
    Sponsor Name:Hospital Comarcal de Laredo. Sección de Digestivo
    Full Title: Ensayo clínico unicéntrico, simple ciego y aleatorizado de comparación de la eficacia erradicadora de primera línea frente al Helicobacter pylori entre la triple terapia convencional oral con clari...
    Medical condition: Situaciones clínicas donde esté recomendada la erradicación del Helicobacter Pylori: (ej. úlcera gastroduodenal, en familiares de primer grado de pacientes con cáncer gástrico o pacientes con dispe...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019376 Helicobacter pylori associated gastrointestinal disease LLT
    9.1 10019377 Helicobacter pylori infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-003597-10 Sponsor Protocol Number: CRH103390 Start Date*: 2006-11-04
    Sponsor Name:GlaxoSmithKline Research & Development
    Full Title: Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
    Medical condition: Social Anxiety Disorder (SocAD)
    Disease: Version SOC Term Classification Code Term Level
    8.1 10041242 Social anxiety disorder LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) FI (Completed) SE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 00:57:21 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA